Ileus
What the FDA labels record as adverse events, each one tied back to the evidence it came from.
What is Ileus?
Functional bowel obstruction, listed in Section 6.2 (postmarketing reports) of the GLP-1 labels since FDA's 2023 updates.
The evidence pulls both ways: Sodhi's JAMA 2023 cohort found HR 4.22 for bowel obstruction, while the Ueda Scandinavian cohort in 2024 found HR 0.83. A fair summary quotes both.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Ileus comes up on this site
On GLP Watchdog, Ileus comes up in 3 research articles.
Other terms under Side effects
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers